211 related articles for article (PubMed ID: 21368504)
1. [A case of interstitial lung diseases in patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX)].
Nakagawa M; Hamada A; Yoshihara Y; Ishizaka T; Fukushima M; Takahashi N; Sawada R; Mukai J
Gan To Kagaku Ryoho; 2011 Feb; 38(2):317-20. PubMed ID: 21368504
[TBL] [Abstract][Full Text] [Related]
2. Interstitial lung disease associated with FOLFOX chemotherapy.
Lim JH; Kim H; Choi WG; Lee MH
J Cancer Res Ther; 2010; 6(4):546-8. PubMed ID: 21358098
[TBL] [Abstract][Full Text] [Related]
3. Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).
Jung KH; Kil SY; Choi IK; Seo JH; Shin C; Kim YS; Kim JH
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1181-2. PubMed ID: 17044215
[No Abstract] [Full Text] [Related]
4. [Epiphora in a patient receiving FOLFOX therapy].
Yatsuda C; Niimi M; Ono Y; Uto N; Iwagami E; Tanaka E; Yamato M
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1989-91. PubMed ID: 19011359
[TBL] [Abstract][Full Text] [Related]
5. [A case of locally advanced rectal cancer responding to FOLFOX].
Kume S; Kubota T; Takahashi M; Hashimoto D; Hirata T; Torigoe Y; Ikeda O
Gan To Kagaku Ryoho; 2009 Apr; 36(4):659-61. PubMed ID: 19381043
[TBL] [Abstract][Full Text] [Related]
6. Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report.
Garrido M; O'Brien A; González S; Clavero JM; Orellana E
Chest; 2007 Dec; 132(6):1997-9. PubMed ID: 18079234
[TBL] [Abstract][Full Text] [Related]
7. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
Shitara K; Munakata M; Muto O; Kasai M; Okada R; Mitobe S; Sakata Y
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1079-84. PubMed ID: 17637544
[TBL] [Abstract][Full Text] [Related]
8. [A case of drug-induced interstitial pneumonitis after chemotherapy with UFT and leucovorin for multiple lung metastases of rectal cancer].
Takagi K; Kawamoto K; Ikeda H; Itoh T
Gan To Kagaku Ryoho; 2011 Jun; 38(6):1025-7. PubMed ID: 21677501
[TBL] [Abstract][Full Text] [Related]
9. [Two cases of interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX)].
Ohori H; Takahashi M; Ogasawara N; Suzuki M; Miyate Y; Kato S
Gan To Kagaku Ryoho; 2009 Feb; 36(2):295-8. PubMed ID: 19223749
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
[TBL] [Abstract][Full Text] [Related]
11. Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report.
Mitsuboshi S; Kozakai H; Yamada H; Nagai K; Furukawa T; Aizawa K
J Oncol Pharm Pract; 2018 Oct; 24(7):540-543. PubMed ID: 28696176
[TBL] [Abstract][Full Text] [Related]
12. [Two cases of interstitial pneumonia caused by cetuximab plus mFOLFOX6 therapy in metastatic colorectal cancer patients].
Shioiri M; Hasegawa M; Tanaka H; Toura I; Kudo S; Sato K; Inoue K; Nakanishi T; Nishiyama S; Takebe S; Ogino Y; Ohsaki S; Nagashima Y
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2198-200. PubMed ID: 23268022
[TBL] [Abstract][Full Text] [Related]
13. Interstitial lung disease during chemotherapy combined with oxaliplatin and/or bevacizumab in advanced colorectal cancer patients.
Usui K; Katou Y; Furushima K; Tanaka Y; Tanai C; Ishihara T
Jpn J Clin Oncol; 2011 Apr; 41(4):498-502. PubMed ID: 21303791
[TBL] [Abstract][Full Text] [Related]
14. [A case of unresectable rectal cancer with severe pelvic infiltration responding to FOLFOX].
Yamazoe S; Yamaguchi K; Terasawa H; Ojima T; Tsujimura H; Shimomura T
Gan To Kagaku Ryoho; 2011 Jan; 38(1):125-8. PubMed ID: 21368473
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin-induced immune mediated thrombocytopenia.
Beg MS; Komrokji RS; Ahmed K; Safa MM
Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of metastatic colorectal cancer.
Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
[TBL] [Abstract][Full Text] [Related]
17. [A case of recurrent rectal cancer with lymphangiosis carcinomatosa successfully treated with modified FOLFOX6 therapy].
Furuta R; Ina K; Kataoka T; Nagao S; Kayukawa S; Mori F; Masaki A; Ando T; Goto H
Gan To Kagaku Ryoho; 2008 May; 35(5):849-52. PubMed ID: 18487928
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer.
Luo HY; Xu RH; Zhang L; Li YH; Shi YX; Lin TY; Han B; Wang F; Qiu MZ; He YJ; Guan ZZ
Chemotherapy; 2008; 54(3):228-35. PubMed ID: 18560231
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer.
Fuse N; Doi T; Ohtsu A; Takeuchi S; Kojima T; Taku K; Tahara M; Muto M; Asaka M; Yoshida S
Jpn J Clin Oncol; 2007 Jun; 37(6):434-9. PubMed ID: 17656481
[TBL] [Abstract][Full Text] [Related]
20. [Fifth-line chemotherapy for metastatic gastric cancer--a case responding to modified FOLFOX 6].
Sagawa T; Sato Y; Takayama T; Kuroda H; Hirakawa M; Abe S; Iyama S; Sakamaki S; Kato J; Niitsu Y
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1467-71. PubMed ID: 17876148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]